# Effects of probiotics on heart failure: a systematic review and meta-analysis

## TL;DR

This study reviews and analyzes the effects of probiotics on heart failure, finding some benefits in cardiac function and inflammation but no impact on mortality or certain biomarkers.

## Contribution

The paper provides a systematic review and meta-analysis of probiotics' effects on heart failure, offering new insights into their potential as an adjunct therapy.

## Key findings

- Probiotics slightly improved cardiac function indicators like LVEF and LVESV.
- They reduced inflammatory markers such as hs-CRP, IL-6, and TNF-α.
- Probiotics had no effect on NT-proBNP, activity endurance, TMAO, or mortality.

## Abstract

Heart failure (HF) is a serious clinical syndrome with substantial health threats. Emerging studies link intestinal flora dysbiosis to HF onset and progression. Although probiotics are thought to regulate gut microbiota, the specific impact of probiotics on HF remains unclear, highlighting the need for systematic evaluation.

As of 9 September 2025, we searched eight major academic databases using a predefined protocol for data extraction and quality assessment. Subsequently, a meta-analysis was conducted using Review Manager 5.4 and Stata 18. Forest plots were used to analyse the effect size, and publication bias was evaluated through funnel plots.

Ultimately, 11 of the studies met the inclusion criteria for the systematic review. The results showed that probiotics have a slight beneficial effect on cardiac function indicators (LVEF, LVESV), reduced the levels of inflammatory factors (hs-CRP, IL-6, TNF-α), regulated the proportion of dominant gut bacteria, and decreased the readmission rates of patients with HF. However, no beneficial effects were found on NT-proBNP, activity endurance, TMAO, and mortality.

Probiotics exert cardioprotective effects and can serve as adjunctive therapy for HF management. Future high-quality, large-sample clinical studies are needed to further clarify their long-term efficacy and optimal intervention strategies.

Details of the protocol for this systematic review were registered on PROSPERO (CRD420251083960).